학술논문
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial
Document Type
Article
Author
Source
In: Nature Medicine . (Nature Medicine, January 2024, 30(1):229-239)
Subject
Language
English
ISSN
1546170X
10788956
10788956